Elanco Animal Health Inc. ELAN Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $785M+33.3% | $589M-3.0% | $607M-14.9% | $713M+4.2% | $684M+31.8% | ||
| $57M-28.7% | $80M+53.8% | $52M+8.3% | $48M+20.0% | $40M-13.0% | ||
| $57M+121% | -$276M-712% | -$34M-409% | $11M-83.6% | $67M— | ||
| $316M+6,420% | -$5M-103% | $178M-26.4% | $242M-7.3% | $261M— | ||
| $144M+180% | -$179M-9,050% | $2M-97.3% | $73M-27.0% | $100M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Elanco Animal Health Inc.'s revenue?
- Elanco Animal Health Inc. (ELAN) generated $4.9B in revenue over the trailing twelve months, up 10.5% year over year.
- Is Elanco Animal Health Inc. profitable?
- Elanco Animal Health Inc. is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months, a -4.9% net margin.
- What is Elanco Animal Health Inc.'s earnings per share?
- Elanco Animal Health Inc.'s diluted EPS over the trailing twelve months is $-0.50.
- Where does Elanco Animal Health Inc.'s income statement data come from?
- Every line is extracted from Elanco Animal Health Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
